What does CJC-1295 with DAC do? Learn how this long-acting growth hormone secretagogue works, how it differs from no-DAC versions, typical dosing, and safety.
CJC-1295 with DAC is a long-acting growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release more growth hormone, which raises IGF-1 levels. The DAC, or Drug Affinity Complex, lets the peptide bind to albumin in the blood and remain active for about 6 to 8 days. It is not FDA-approved for human use and is sold only as a research chemical.
What CJC-1295 With DAC Does in the Body
CJC-1295 with DAC mimics natural GHRH. It binds to GHRH receptors in the pituitary, triggering growth hormone release. Because the DAC extends its half-life, the stimulation continues for days instead of minutes.
In research models, this sustained activity has been linked to:
- Higher circulating growth hormone levels
- Increased IGF-1, which mediates many growth hormone effects
- A steady, non-pulsatile GH elevation rather than natural bursts
Natural growth hormone release happens in pulses, especially during deep sleep. CJC-1295 with DAC flattens that rhythm by keeping the receptor signal active. Researchers debate whether this steady elevation is helpful or whether it disrupts the body's normal feedback loops.
CJC-1295 With DAC vs Without DAC: Key Differences
The main difference is half-life. CJC-1295 without DAC—often called Mod GRF (1-29)—has a half-life of about 30 minutes. The DAC version lasts roughly 6 to 8 days. That changes dosing frequency, the shape of the GH pulse, and the side effect profile.
If you are comparing what is cjc-1295 with dac vs without dac, the albumin binding is the key. The DAC attaches to albumin, which protects the peptide from rapid breakdown. Without DAC, the peptide is cleared quickly.
| Feature | CJC-1295 With DAC | CJC-1295 Without DAC |
|---|---|---|
| Half-life | About 6–8 days | About 30 minutes |
| Typical research dosing | 1–2 times per week | 2–3 times per day |
| GH release pattern | Continuous elevation | Pulsatile bursts |
| FDA status for human use | Not approved | Not approved |
Searching what does cjc 1295 no dac do usually leads to stacking protocols with a GHRP to mimic natural pulses. The DAC version is often studied alone for sustained IGF-1 elevation.
CJC-1295 With DAC Dosage: What Research Suggests
There is no FDA-approved human dosage for CJC-1295 with DAC. In published research and online discussions, cjc-1295 with dac dosage typically ranges from 1 mg to 2 mg per week, sometimes split into two injections. Some protocols use 2 mg every two weeks.
A vial labeled 5 mg contains 5 milligrams of lyophilized powder. Researchers reconstitute it with bacteriostatic water, but the correct volume depends on the desired concentration. No safe or effective human dose has been established.
The question how much cjc 1295 with dac should i take has no evidence-based answer. Self-dosing with a research chemical is risky because purity, sterility, and actual content are not guaranteed.
| Reported Protocol | Frequency | Weekly Total |
|---|---|---|
| Low-dose research | 1 mg once weekly | 1 mg |
| Common forum protocol | 1 mg twice weekly | 2 mg |
| Alternate forum protocol | 2 mg every 2 weeks | 1 mg average |
What Reddit and Forums Say About CJC-1295 With DAC
Reddit discussions about CJC-1295 with DAC often describe improved sleep, recovery, and body composition. These reports are not clinical evidence. They frequently mix CJC-1295 with DAC with other peptides, making it impossible to isolate its effects.
Dosage threads on Reddit show a wide range, from 1 mg per week to 2 mg every other day. That inconsistency reflects the lack of standardized dosing and the unregulated market.
Safety, Legality, and Product Quality
CJC-1295 with DAC is not approved by the FDA for human use. It is a research chemical, and selling it for human consumption is illegal in the United States. Listings for cjc-1295 with dac for sale are intended for laboratory research only.
Potential side effects reported in research and anecdotes include injection-site reactions, water retention, numbness or tingling, and changes in blood sugar. Growth hormone and IGF-1 elevation can affect insulin sensitivity. Anyone considering it should talk to a healthcare professional.
There is no long-term safety data for CJC-1295 with DAC in healthy humans.
Product quality is another concern. Because the market is unregulated, purity varies widely. A certificate of analysis from a third-party lab is the minimum proof of identity and purity, but even COAs can be forged.
- Look for a recent, independent COA with batch numbers
- Check whether the testing lab is accredited and not owned by the vendor
- Avoid products with no testing information or vague labels
- Remember that purity does not equal safety
Even a 99% pure peptide can cause harm if the dose is wrong or if it is not sterile. Research chemicals are not manufactured to pharmaceutical standards.
The Bottom Line
CJC-1295 with DAC is a long-acting GHRH analog that raises growth hormone and IGF-1 for days after a single injection. It differs from the no-DAC version mainly in half-life and dosing frequency. It is not FDA-approved, has no established human dose, and should only be handled in a legal research setting. If you have health concerns about growth hormone, consult a doctor rather than self-experimenting.
Frequently Asked Questions
Is CJC-1295 with DAC FDA-approved?
No. CJC-1295 with DAC is not FDA-approved for human use in the United States. It is sold as a research chemical, and vendors may not legally market it for human consumption.
How long does CJC-1295 with DAC stay in your system?
The DAC modification binds the peptide to albumin, giving it a half-life of about 6 to 8 days. That means a single injection can keep growth hormone and IGF-1 elevated for several days.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 without DAC has a half-life of roughly 30 minutes and produces short, pulsatile growth hormone release. The DAC version lasts 6 to 8 days and creates a continuous elevation, which changes dosing frequency and the overall hormone pattern.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.